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Abstract
Background: Cell-free protein synthesis (CFPS) is a rapid and high throughput technology for
obtaining proteins from their genes. The primary energy source ATP is regenerated from the
secondary energy source through substrate phosphorylation in CFPS.
Results: Distinct from common secondary energy sources (e.g., phosphoenolpyruvate – PEP,
glucose-6-phosphate), maltodextrin was used for energizing CFPS through substrate
phosphorylation and the glycolytic pathway because (i) maltodextrin can be slowly catabolized by
maltodextrin phosphorylase for continuous ATP regeneration, (ii) maltodextrin phosphorylation
can recycle one phosphate per reaction for glucose-1-phosphate generation, and (iii) the
maltodextrin chain-shortening reaction can produce one ATP per glucose equivalent more than
glucose can. Three model proteins, esterase 2 from Alicyclobacillus acidocaldarius, green fluorescent
protein, and xylose reductase from Neurospora crassa were synthesized for demonstration.
Conclusion: Slowly-metabolized maltodextrin as a low-cost secondary energy compound for
CFPS produced higher levels of proteins than PEP, glucose, and glucose-6-phospahte. The
enhancement of protein synthesis was largely attributed to better-controlled phosphate levels
(recycling of inorganic phosphate) and a more homeostatic reaction environment.
Background
Cell-free protein synthesis (CFPS) is widely used for the
production of in vivo cytotoxic, regulatory, or unstable
proteins that are difficult to express in living cells [1-3]
and for the incorporation of unnatural amino acids into
protein polypeptides [4-6]. Also, CFPS can be applied for
high-throughput screening of target proteins [7,8], func-
tional tool for proteomics [7,9], and the development of
point-of-care medicines [10,11]. Also, CFPS is the fastest
method to produce a desired protein within one day
[9,12].
Protein synthesis is an energy-intensive process. The pri-
mary energy source ATP is regenerated from the secondary
energy source through substrate phosphorylation in CFPS
[13]. Common secondary energy compounds such as cre-
atine phosphate, phosphoenolpyruvate (PEP), acetate
phosphate, glucose-6-phosphate (G6P), 3-phosphoglyc-
erate, and fructose-1,6-biphosphate, contain high-energy
phosphate bonds for regenerating ATP. Consequently,
ATP regeneration accompanied with the consumption of
phosphate-containing substrate leads to an increase in
inorganic phosphate. High concentrations of inorganic
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phosphate severely impair protein biosynthesis, likely due
to precipitation of free magnesium ions [14,15]. Magne-
sium ions are essentially important for nucleoside tri-
phosphate synthesis, protein translation, and translation
termination [16,17].
In order to mitigate the accumulation of free phosphate,
Swartz and his coworkers have studied the replacement of
costly phosphate-containing secondary energy com-
pounds by using phosphate-free secondary energy com-
pounds (e.g., glucose or pyruvate) [18,19]. Pyruvate, an
end product of glycolysis, coupled with the Pediococcus sp.
pyruvate oxidase, catalase, and acetate kinase to produce
one ATP per pyruvate without accumulation of phosphate
can be used for long-time CFPS [19]. Further improve-
ments in utilizing glucose through the glycolytic pathway
to acetate and lactate have been achieved for more effi-
cient ATP regeneration [14,18,20]. Figure 1 shows that
glucose and G6P can produce two and three ATP, respec-
tively, through glycolysis to pyruvate. Extra ATP can be
produced through the PANOx system with addition of
nicotinamide adenine dinucleotide (NAD+) and coen-
zyme A (CoA) that help convert pyruvate to acetate and
lactate. In addition, glucose as the secondary energy
source is much less expensive than any phosphate-con-
taining compounds or phosphate-free pyruvate [18].
In addition to the effects of phosphate and the costs of a
secondary energy source, stable pH is vital for high pro-
tein yields [18,21]. It is well known that well-controlled
continuous CFPS systems have high protein yields [3,22].
But continuous CFPS systems with complicated configu-
rations are hard to scale up for high-throughput applica-
tions and are not efficient for utilizing costly reagents
[21]. It would be appealing to use slowly-metabolized sec-
ondary energy sources in batch reactions, which likely
mimic the well-controlled continuous reactions.
In this study, to avoid phosphate accumulation and to
maintain a relatively homeostatic reaction environment
Pathway of maltodextrin phosphorolysis and glycolysis for regeneration of ATP and recycling of inorganic phosphate Figure 1
Pathway of maltodextrin phosphorolysis and glycolysis for regeneration of ATP and recycling of inorganic 
phosphate. Maltodextrin phosphorylase, MP; phosphoglucomutase, PGM; and hexokinase, HK.BMC Biotechnology 2009, 9:58 http://www.biomedcentral.com/1472-6750/9/58
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for CFPS, we designed a novel ATP regeneration system
starting from low-cost maltodextrin and ending with ace-
tate and lactate, by using a combination of maltodextrin
phosphorylase, phosphoglucomutase, glycolysis, and the
PNAOx system.
Results
A new ATP regeneration pathway
The ATP regeneration scheme was designed to involve
maltodextrin phosphorolysis, glycolysis, and PANOx
pathway (Fig. 1). Maltodextrin was slowly cleaved into
glucose-1-phosphate (G1P) in the presence of inorganic
phosphate catalyzed by maltodextrin phosphorylase (Eq.
1). G1P was further converted into G6P by phosphogluco-
mutase (Eq. 2). The G6P generation rate from maltodex-
trin can be controlled by the amounts of the added
maltodextrin phosphorylase and phosphoglucomutase.
We tested the effects of maltodextrin phosphorylase and
phosphoglucomutase loading on the EST2 yields. With-
out addition of maltodextrin phosphorylase and phos-
phoglucomutase, the EST2 expression levels by E. coli cell
extract plus maltodextrin were very low (data not shown).
The optimal enzyme additions were found to be 0.009 U
of maltodextrin phosphorylase and 0.06 U of phos-
phoglucomutase per 30 μL of the reaction solution. Three
moles of ATP can be generated per mole of G6P through
the glycolytic pathway (Eq. 3). The PANOx system can
convert two molecules of pyruvate to lactate and acetate
plus one ATP (Eq. 4).
The overall pathway as designed can generate four ATP per
glucose equivalent of maltodextrin (Eq. 5).
Synthesis of esterase
Esterase 2 (EST2) from Alicyclobacillus acidocaldorius, a 34
kDa protein, was chosen as a reporter protein for in vitro
protein synthesis [4,23,24]. Figure 2A shows the profiles
of the synthesized active protein EST2 energized by mal-
todextrin, glucose, PEP, and G6P, respectively. The reac-
tion energized by maltodextrin had the highest protein
level, at 0.26 mg EST2 per mL, higher than the other com-
pounds (0.18 mg EST2 per mL, PEP; 0.13 mg EST2 per
GP H OG G P ni n ++ → + − 21 1 (1)
GP GP 16 → (2)
G P  ADP  P  pyruvate  ATP i 63 2 2 3 ++ → + (3)
2 pyruvate ADP P lactate acetate ATP i ++ → + +
(4)
G  ADP  P H O G lactate acetate  ATP ni n ++ + → +++ − 44 4 21
(5)
The synthesized EST2 energized by maltodextrin (MD), glucose, G6P, and PEP Figure 2
The synthesized EST2 energized by maltodextrin (MD), glucose, G6P, and PEP. (A) Profile of the EST2 synthesis 
levels based on its activity assays. The data were measured in triplicate. (B) Images of SDS-PAGE with stained esterase activity 
(magenta bands) for cell-free protein synthesis after incubation for 3 hours.BMC Biotechnology 2009, 9:58 http://www.biomedcentral.com/1472-6750/9/58
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mL, glucose; 0.09 mg EST2 per mL, G6P). EST2 activity
staining on polyacrylamide gel was used to analyze the
synthesized proteins after SDS-PAGE separation (Fig. 2B)
[25]. The EST2 activity staining helps locating EST2 from
a high background of other proteins [26]. The quantitative
results based on the EST2 enzyme activity suggested that
using maltodextrin as a secondary energy source for cell-
free protein synthesis produced more EST2 than the other
three energy sources.
Figure 3A presents the profile of inorganic phosphate con-
centration during CFPS. In the cases of phosphate-free sec-
ondary energy compounds (maltodextrin and glucose),
inorganic phosphate concentration was nearly constant or
even decreased, due to substrate phosphorylation, which
consumes free phosphate. In contrast, in the cases of
phosphate-containing compounds (PEP and G6P), phos-
phate levels rose to approximately 26 mM and then lev-
elled off. These increases in phosphate were mainly due to
the non-productive hydrolysis of PEP and G6P by the
endogenous phosphatases of the E. coli cell extract. Phos-
phate recycling by maltodextrin consumption was effi-
cient for avoiding any possible accumulation of
phosphate, resulting in high protein yields.
Changes in pH were measured during the protein synthe-
sis process (Fig. 3B). At the beginning, the initial pHs for
the four reactions were around pH 7.4–7.6. The pH from
the reactions energized by maltodextrin, PEP, glucose and
G6P decreased slowly to 6.9, 6.6, 6.5 and 6.2 after one
hour, respectively, and then levelled off. The reaction
energized by maltodextrin exhibited the least pH fluctua-
tion, from 7.6 to 6.9.
Concentrations of ATP in the reaction mixtures were
measured during the process of protein synthesis (Fig.
3C). In the case of maltodextrin, the ATP level decreased
slowly; its levels remained above 0.15 mM for the first two
hours. In the case of PEP, the ATP level was highest at the
beginning, quickly decreased from 2.67 mM to 0.58 mM,
and then levelled off. PEP was an easily metabolized sub-
strate, resulting in higher levels of ATP as compared to
other slowly-metabolized substrates of maltodextrin,
G6P, and glucose. The measured ATP concentration was
the combinatorial result of continuous in situ ATP regen-
eration and ATP consumption for protein synthesis and
nonproductive hydrolysis. Recently, it was found that
CFPS had a low ATP binding constant (i.e., Km
ATP = 27
uM) [27], suggesting that ATP levels in CFPS (Fig. 3C)
were saturated, i.e., the protein synthesis rates did not
depend on the ATP levels [19,21].
Synthesis of CBM-GFP and xylose reductase
Two other proteins (CBM-GFP and xylose reductase) were
investigated for CFPS energized by maltodextrin, glucose,
PEP, and G6P, respectively. Figure 4 shows that the final
CBM-GFP and xylose reductase concentrations are 0.14
and 0.21 mg per mL, respectively, when maltodextrin was
used as secondary energy source. These values were higher
than those powered by PEP, G6P and glucose but the
comparative advantages depended on the protein type.
Slowly metabolized, low-cost maltodextrin may be a good
secondary energy source for CFPS without the need for
intensive optimization.
Discussion
CFPS energized by maltodextrin presented relatively high
levels of EST2, CBM-GFP and xylose reductase as com-
pared with three other secondary energy sources – glu-
cose, G6P, and PEP. Maltodextrin provided relatively
homeostatic conditions, such as no phosphate accumula-
tion and less fluctuation in pH (Fig. 3A &3B). Slowly
Profile of inorganic phosphate, pH and ATP levels Figure 3
Profile of inorganic phosphate, pH and ATP levels. (A) inorganic phosphate concentration, (B) pH, and (C) ATP levels in 
CFPS energized by maltodextrin, glucose, G6P, and PEP, respectively. The data were measured in triplicate.BMC Biotechnology 2009, 9:58 http://www.biomedcentral.com/1472-6750/9/58
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metabolized maltodextrin in batch CFPS was somewhat
like continuous CFPS with regard to well-controlled reac-
tion conditions.
The major advantages of using slowly-metabolized malto-
dextrin are to avoid inorganic phosphate accumulation to
inhibitory levels and to maintain a relatively homeostatic
environment (e.g., phosphate, pH, and ATP) for protein
synthesis. Proper levels of inorganic phosphate are also
required for effective synthesis of nucleoside triphosphate
(NTP) from nucleoside diphosphate (NDP) for high level
protein synthesis [18,19]. Using phosphate-free malto-
dextrin does not release net phosphate. In contrast, it can
decrease free phosphate levels by substrate phosphoryla-
tion and keep phosphate levels nearly constant. In addi-
tion, maltodextrin is not a substrate of E. coli endogenous
phosphatases. Therefore, the challenge associated with
non-productive hydrolysis of phosphate-containing com-
pounds [19,28] has been partially addressed by using
maltodextrin.
The importance of pH control in CFPS has long been rec-
ognized [18,21]. More stable pH in the case of maltodex-
trin was largely attributed to no phosphate accumulation
and less formation of organic acids (e.g., lactate and ace-
tate) due to the generation of more ATP per substrate con-
sumed (Additional file 1). The latter speculation has been
validated by product assays, in which 40, 18 and 18 mM
lactate were produced from glucose, maltodextrin and
PEP, respectively, after a 1 hour reaction. Swartz and his
coworkers also reported that a strong pH-capacity buffer
(Bis-Tris, pH 6.5) increased protein synthesis levels [18].
EST2 was used as a major model protein for CFPS in this
study. Due to its high-sensitivity and thermal stability, it
had been applied not only for CFPS [4,23,24] but also for
detecting nucleic acid hybridization [29,30]. Since EST2
has a specific activity of 1100 U/mg based on p-nitrophe-
nylbutyrate at 25°C [31], its levels can be measured as low
as 72 pM, superior to 14C radioactivity-labelled amino
acids. We also used the Roche High-Yield in vitro protein
synthesis system as a control to express EST2 protein at a
level of 0.21 mg per mL. The previous EST2 levels by CFPS
were 0.15–0.20 mg per mL [24,29]. The expression level
(0.28 mg of EST2 per mL) energized by maltodextrin was
the highest so far.
A number of secondary energy substrates were compared
based on their ATP yields and phosphate release (Addi-
tional file 1). Acetyl-phosphate, creatine-phosphate, 3-
phosphoglycerate (3-PGA), and PEP generated one ATP
and released one inorganic phosphate [13,32-34]. ATP
regeneration potential through the PANOx system was
approximately one ATP per two pyruvate with an acetate/
lactate = ~1:1. In principle, one molecule of glucose, G6P
and fructose-1, 6-biphosphate can regenerate three, four
and five molecules of ATP and release zero, one and two
phosphate, respectively. One glucose equivalent of malto-
dextrin can produce four molecules of ATP, while it does
not release phosphate (Eq. 5). Maltodextrin is better than
glucose because generation of G1P mediated by glucan
phosphorylases from polysaccharides does not consume
ATP so that one molecule of ATP is saved from glucose
phosphorylation catalyzed by ATP-dependent hexokinase
[35-37]. It is well known that ATP consumption of CFPS
is not coupled to ATP regeneration [18,20], which is dif-
ferent from in vivo protein synthesis [38,39]. But slowly-
metabolized maltodextrin can enhance the protein syn-
thesis yield and decrease energy dissipation because they
can avoid an initial high concentration of the secondary
energy compound, most of which was hydrolyzed by E.
coli  endogenous phosphatases. For example, approxi-
mately 70% of 30 mM PEP was hydrolyzed within the first
30 min by endogenous phosphatase in the E. coli cell
extract [19].
In addition to the high product levels associated with
more homeostatic conditions, maltodextrin is a low-cost
substrate. The secondary energy compound cost accounts
for a significant fraction of total CFPS cost [18,40]. For
example, PEP costs $1.20 per mL of reaction mixture (30
mM PEP), while glucose and maltodextrin cost only
$0.0002 and $0.001 per mL of reaction mixture, respec-
tively, based on Sigma-Aldrich prices. Although a small
amount of maltodextrin phosphorylase (0.009 U per reac-
tion) and phosphoglucomutase (0.06 U per reaction)
added some extra costs for the entire systems, two over-
expressed recombinant enzymes in E. coli were produced
The CFPS for active EST2, active CBM-GFP, and purified  xylose reductase by using different secondary energy com- pounds Figure 4
The CFPS for active EST2, active CBM-GFP, and 
purified xylose reductase by using different second-
ary energy compounds. The data were measured in tripli-
cate.BMC Biotechnology 2009, 9:58 http://www.biomedcentral.com/1472-6750/9/58
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and used in this study [41,42]. It is anticipated that costs
of supplementary enzymes will be decreased to very low
levels. The use of maltodextrin in CFPS can not only dra-
matically decrease the cost of secondary energy but also
increase synthesized protein levels.
Conclusion
The use of maltodextrin as a secondary energy source for
cell-free protein synthesis was shown to synthesize pro-
teins with several advantages: relatively high protein syn-
thesis, no phosphate accumulation, little change in pH,
and low cost. The slowly generated G1P from maltodex-
trin followed by glycolysis provided relatively homeo-
static CFPS environments.
Methods
Materials
A total tRNA mixture from E. coli MRE600 and the in vitro
protein synthesis system (RTS 100 E. coli High-yield Kit)
were obtained from Roche Diagnostics (Indianapolis, IN,
USA). The 20 amino-acid mixture was purchased from
Spectra Stable Isotopes (Columbia, MD, USA). The
recombinant α-glucan phosphorylase and phosphogluco-
mutase from Clostridium thermocellum were prepared as
described elsewhere [41,42]. The plasmid pIVEX2.3d-est2
encoding the esterase 2 (est2) from Alicyclobacillus acido-
caldarius  was described elsewhere [24]. The plasmid
pET26b-XR encoding xylose reductase from Neurospora
crassa  was described elsewhere [43]. The plasmid pCG
encoding cellulose-binding module and green fluorescent
protein (CBM-GFP) was described previously [44]. Pfx50
DNA polymerase and Ni-NTA agarose were purchased
from Invitrogen Co. (Carlsbad, CA, USA). E. coli
Bl21(DE3) was purchased from Novagen (Gibbstown, NJ,
USA). The rest of the reagents were purchased from Sigma-
Aldrich (St. Louis, MO, USA).
Construction of the expression plasmids
The plasmids of pIVEX2.3d-xr for xylose reductase and
pIVEX2.3d-cg for CBM-GFP were constructed based on
the plasmid pIVEX2.3d-est2. The DNA fragment of xylose
reductase gene was amplified by the primers Xr-F (5'-
GACTGACTCATATGGTTCCTGCTATCAAGCTCAAC-3')
and Xr-R (5'-GACTGACTTGATCATCAGTGGTGGTGGT-
GGTGG-3') on the DNA template of pET26b-XR (bolded
nucleotide sequences are NdeI and BclI sites). The plas-
mid pIVEX2.3d-xr was constructed after NdeI- and BclI-
digestion of PCR product and ligation with the NdeI- and
BamHI-digested plasmid pIVEX2.3d-est2. The plasmid
pIVEX2.3d-cg for CBM-GFP was constructed by ligation of
the NdeI- and BamHI-digested CBM-GFP DNA fragment
from the plasmid pCG and ligation with the NdeI- and
BamHI-digested pIVEX2.3d-est2. The plasmids were vali-
dated by DNA sequencing.
Preparation of the E. coli S12 extract
The  E. coli S12 extracts were prepared from E. coli
BL21(DE3) according to the Kim protocol [45]. The strain
was grown in 4 litres of 2xYT medium in a 6.6-L NBS Bio-
Flo 310 Bioreactor (Edison, NJ). The cultivation condi-
tions were 37°C, 200 rpm, and 1.0 vvm. When the
absorbance (A600) reached 0.6, a final concentration of 1
mM IPTG was added, and then agitation and airflow rates
were increased to 300 rpm and 2.0 vvm respectively. The
cells were harvested in the middle exponential phase (A600
= ~4.0). After centrifugation, the cell pellets were washed
by an ice-cooled 10 mM Tris-acetate buffer (pH 8.2) with
60 mM potassium glutamate, 14 mM magnesium acetate,
1 mM DTT, and 0.05% beta-mercaptoethnaol three times
and then were stored in -80°C. The cell extract was pre-
pared by French Press at a pressure of 20,000 psi. After
centrifugation at 12,000 relative centrifugal force (RCF)
for 10 min, the supernatant was briefly incubated at 37°C
in 10 mM Tris-acetate buffer (pH 8.2) with 60 mM potas-
sium glutamate, 14 mM magnesium acetate, 1 mM DTT
for 10 min and then was stored at -80°C for future cell-
free protein synthesis. The S12 extracts had 33 mg of cel-
lular protein per mL.
Cell-free protein biosynthesis
The CFPS mixture (30 μL, final volume) consisted of 57
mM of Hepes-KOH (pH 8.2), 1.2 mM of ATP, 0.85 mM of
CTP, GTP and UTP (each), 0.6 mM cAMP, 2 mM of DTT,
0.17 mg per mL of E. coli MRE600 total tRNA mixture, 90
mM of potassium glutamate, 80 mM of ammonium ace-
tate, 12 mM of magnesium acetate, 34 μg per mL of l-5-
formyl-5,6,7,8-tetrahydrofolic acid, 1.5 mM each of 20
amino acids, 2% (w/v) of PEG 8000, 10 U per mL of pyru-
vate kinase, 5 nM template DNA, 0.33 mM NAD, 0.26
mM CoA, and 27% (v/v) of the S12 extract. The secondary
energy compound (30 mM) was either PEP, glucose, G6P,
or maltodextrin. CFPS was conducted at 37°C. When mal-
todextrin was used as a secondary energy source, the reac-
tion solution was supplemented with 0.009 U of the
recombinant C. thermocellum α-glucan phosphorylase and
0.06 U of phosphoglucomutase to generate glucose-1-
phosphate (G1P) from maltodextrin for energizing CFPS.
Esterase activity staining on polyacrylamide gel
The protein esterase 2 in the CFPS solution was separated
by SDS-polyacrylamide gel in a 100 mM Tris-HCl (pH
7.5). After electrophoresis and EST2 renaturation by
removing SDS, the gel was mixed with the substrate (β-
naphthylacetate) and the product (β-naphthol) was
linked with Fast Blue BB for the formation of an insoluble
color complex, indicating the presence and amount of
EST2 [24,46]. Subsequently, the other proteins in the gels
were strained by the Coomassie blue dye [47].BMC Biotechnology 2009, 9:58 http://www.biomedcentral.com/1472-6750/9/58
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Protein assays
Molar concentration of EST2 (mol/L) was determined by
the ratio of the spectrophotometric assay of esterase activ-
ity to its molar-specific activity according to [EST2] =
(A405/min-0.016)/6.10 × 108, where A405/min is absorb-
ance of a 1-cm path length at 405 nm per minute for a
EST2 concentration ranging from 0.02 to 1 nM [31]. Two
μL of the reaction mixture were withdrawn and diluted
100-fold in an assay buffer (30 mM Tris-HCl, pH 7.5, 200
mM NaCl and 0.05% Triton X-100). Either 2 μL of the
diluted EST2 solution or a further 10-fold diluted EST2
solution was mixed to a final 250 μL of the assay buffer
containing 0.2 mM p-nitrophenylbutyrate. The synthe-
sized CBM-GFP protein was quantified in a 50 mM Hepes
solution (pH 7.0) using a BioTek multi-detection micro-
plate reader with a reference of purified CBM-GFP
expressed by E. coli [44,48]. The synthesized XR protein
was determined by Ni-NTA adsorption and desorption
followed by the Bio-Rad Bradford assay.
Other assays
Concentration of inorganic phosphate in the reaction
mixture was determined by using a mild-pH phosphate
assay as described elsewhere [49]. Concentration of ATP
was measured by the Promega ATP assay kit (Madison,
WI) based on the known concentration of ATP standards,
as described elsewhere [20] with modifications. A 2 μL
reaction mixture was diluted by 100-fold in the EST2
activity assay buffer, and then 50 μL diluted solution was
added into 450 μL of water that had been boiled to dena-
ture ATP hydrolysis enzymes, i.e. ATPase and phos-
phatases [50]. The diluted solution stood on ice until the
ATP assay. The pH of the CFPS solution was measured by
using an Orion 9810BN micro-pH probe (Beverly, MA) at
37°C. Concentration of lactate was measured with a Beck-
man-Coulter HPLC (Fullerton, CA) equipped with the
Bio-Rad HPX-87 column as described elsewhere [51].
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